Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.

Outside researchers criticized a new cardiovascular disease risk calculator promoted by a top health association and warned that it could improperly render as many as 16 million people ineligible for ...